Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro

Fitoterapia

Volumn 91, Issue , 2013, Pages 173-179

  Song, Yanqin ^a   Zhao, Feng ^a   Zhang, Leiming ^a   Du, Yuan ^a   Wang, Tian ^a   Fu, Fenghua ^a  

^a YANTAI UNIVERSITY   (China)

Author keywords

Antia inflammatory effect; Ginsenoside Rg1; Glucocorticoids; Synergism

Indexed keywords

CORTICOSTERONE; GINSENOSIDE RE; GINSENOSIDE RG 1; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; UPREGULATION;

MURINAE;

ANTI-INFLAMMATORY EFFECT; CORTICOSTERONE (PUBCHEM CID: 5753); DMSO (PUBCHEM CID: 679); GINSENOSIDE RE (PUBCHEM CID: 73149); GINSENOSIDE RG1; GINSENOSIDE RG1 (PUBCHEM CID: 441923); GLUCOCORTICOIDS; LIPOPOLYSACCHARIDE (PUBCHEM CID: 11970143); MTT (PUBCHEM CID: 64965); SYNERGISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GINSENOSIDES; GLUCOCORTICOIDS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; RECEPTORS, GLUCOCORTICOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885124755     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.09.001     Document Type: Article

References (40)

1. P.J. Barnes Anti-inflammatory actions of glucocorticoids: molecular mechanisms Clin Sci 94 1998 557 572 [PubMed: 20866076] (Pubitemid 28269054)
2. B.M. Vayssière, S. Dupont, A. Choquart, F. Petit, T. Garcia, and C. Marchandeau Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo Mol Endocrinol 11 1997 1245 1255 [PubMed: 9259316] (Pubitemid 28041332)
3. H. Schäcke, H. Rehwinkel, and Asadullah K. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index Curr Opin Investig Drugs 6 2005 503 507 [PubMed: 15912964] (Pubitemid 40613972)
4. C.A. Longui Glucocorticoid therapy: minimizing side effects J Pediatr (Rio J) 83 2007 S163 S177 [PubMed: 18000630]
5. C.X. Liu, and P.G. Xiao Recent advances on ginseng research in China J Ethnopharmacol 36 1992 27 38 [PubMed: 1501490]
6. C. Ling, Y. Li, X. Zhu, C. Zhang, and M. Li Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor Gen Comp Endocrinol 140 2005 203 209 [PubMed: 15639148] (Pubitemid 40082587)
7. D.H. Kim, J.H. Chung, J.S. Yoon, Y.M. Ha, S. Bae, and E.K. Lee Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver J Ginseng Res 37 2013 54 63 [PubMed: 23717157]
8. E.H. Joh, I.A. Lee, I.H. Jung, and D.H. Kim Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation Biochem Pharmacol 82 2011 278 286 [PubMed: 21600888]
9. Y.J. Lee, E. Chung, K.Y. Lee, Y.H. Lee, B. Huh, and S.K. Lee Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor Mol Cell Endocrinol 133 1997 135 140 [PubMed: 9406859] (Pubitemid 27491526)
10. R.Y. Chan, W.F. Chen, A. Dong, D. Guo, and M.S. Wong Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng J Clin Endocrinol Metab 87 2002 3691 3695 [PubMed: 12161497] (Pubitemid 34879514)
11. K.W. Leung, Y.K. Cheng, N.K. Mak, K.K. Chan, T.P. Fan, and R.N. Wong Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells FEBS Lett 580 2006 3211 3216 [PubMed: 16696977] (Pubitemid 43729672)
12. A. Rhule, S. Navarro, J.R. Smith, and D.M. Shepherd Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells J Ethnopharmacol 106 2006 121 128 [PubMed: 18711766]
13. C.F. Wu, X.L. Bi, J.Y. Yang, J.Y. Zhan, Y.X. Dong, and J.H. Wang Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia Int Immunopharmacol 7 2007 313 320 (Pubitemid 46186170)
14. J. Du, B. Cheng, X. Zhu, and C. Ling Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects J Immunol 187 2011 942 950 [PubMed: 21666059]
15. F. Denizot, and R. Lang Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J Immunol Methods 89 1986 271 277 [PubMed: 3486233] (Pubitemid 16080782)
16. T. Ishihara, K. Kohno, S. Ushio, K. Iwaki, M. Ikeda, and M. Kurimoto Tryptanthrin inhibits nitric oxide and prostaglandin E (2) synthesis by murine macrophages Eur J Pharmacol 407 2000 197 204 [PubMed: 11050308]
17. M.C. Berenbaum What is synergy? Pharmacol Rev 41 1989 93 141 [PubMed: 2692037] (Pubitemid 20019599)
18. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol Rev 58 2006 621 681 [PubMed: 16968952]
19. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu Rev Biochem 71 2002 635 700 [PubMed: 12045108] (Pubitemid 34800232)
20. I. Appleton, A. Tomlinson, and D.A. Willoughby Induction of cyclo-oxygenase and nitric oxide synthase in inflammation Adv Pharmacol 35 1996 27 78 [PubMed: 8920204]
21. M. Stefanovic-Racic, J. Stadler, and C.H. Evans Nitric oxide and arthritis Arthritis Rheum 36 1993 1036 1044 [PubMed: 8343180] (Pubitemid 23229279)
22. M.J. Morgan, Y.S. Kim, and Z.G. Liu TNF alpha and reactive oxygen species in necrotic cell death Cell Res 18 2008 343 349 [PubMed: 18301379] (Pubitemid 351333898)
23. A. Cope, R. Ettinger, and H. McDevitt The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire Res Immunol 148 1997 307 312 [PubMed: 9352594] (Pubitemid 27435914)
24. Y.S. Kim, M.J. Morgan, S. Choksi, and Z.G. Liu TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death Mol Cell 26 2007 675 687 [PubMed: 17560373] (Pubitemid 46856240)
25. S. Sakon, X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, and Y. Kojima NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death EMBO J 22 2003 3898 3909 [PubMed: 12881424] (Pubitemid 36975716)
26. V. Baud, and M. Karin Signal transduction by tumor necrosis factor and its relatives Trends Cell Biol 9 2011 327 377 [PubMed: 11514191]
27. P. Andrade, V. Visser-Vandewalle, C. Hoffmann, H.W. Steinbusch, M.A. Daemen, and G. Hoogland Role of TNF-alpha during central sensitization in preclinical studies Neurol Sci 32 2011 757 771 [PubMed: 21559854]
28. G. Rigaud, J. Roux, R. Pictet, and T. Grange In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor Cell 67 1991 977 986 [PubMed: 1683601] (Pubitemid 121001511)
29. K.S. Zaret, and K.R. Yamamoto Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element Cell 38 1984 29 38 [PubMed: 6088072] (Pubitemid 15216532)
30. H. Richard-Foy, and G.L. Hager Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter EMBO J 6 1987 2321 2328 [PubMed: 2822386]
31. S. John, P.J. Sabo, T.A. Johnson, M.H. Sung, S.C. Biddie, and S.L. Lightman Interaction of the glucocorticoid receptor with the chromatin landscape Mol Cel 29 2008 611 624 [PubMed: 18342607] (Pubitemid 351374691)
32. S. John, P.J. Sabo, R.E. Thurman, M.H. Sung, S.C. Biddie, and T.A. Johnson Chromatin accessibility pre-determines glucocorticoid receptor binding patterns Nat Genet 43 2011 264 268 [PubMed: 21258342]
33. A.Y. So, C. Chaivorapol, E.C. Bolton, H. Li, and K.R. Yamamoto Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor PLoS Genet 3 2007 94 99 [PubMed: 17559307]
34. S. John, T.A. Johnson, M.H. Sung, S.C. Biddie, S. Trump, and C.A. Koch-Paiz Kinetic complexity of the global response to glucocorticoid receptor action Endocrinology 150 2009 1766 1774 [PubMed: 19131569]
35. W. Xin, L. Zhang, H. Fan, N. Jiang, T. Wang, and F. Fu Escin attenuates acute lung injury induced by endotoxin in mice Eur J Pharm Sci 42 2011 73 80 [PubMed: 21040784]
36. Y. Zou, T. Tao, Y. Tian, J. Zhu, L. Cao, and X. Deng Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes J Surg Res 183 2013 760 766 [PubMed: 23478085]
37. G.U. Meduri, and G.P. Chrousos Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way? Chest 114 1998 355 360 [PubMed: 9726712] (Pubitemid 28387505)
38. Z.H. Huang, H. Gao, and R.B. Xu Study on glucocorticoid receptors during intestinal ischemia shock and septic shock Circ Shock 23 1987 27 36 [PubMed: 3690811] (Pubitemid 18015055)
39. P.J. Barnes, A.P. Greening, and G.K. Crompton Glucocorticoid resistance in asthma Am J Respir Crit Care Med 152 1995 S125 S140 [PubMed: 7489120]
40. G.J. Molijn, J.W. Koper, C.J. van Uffelen, F.H. de Jong, A.O. Brinkmann, and H.A. Bruining Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock Clin Endocrinol (Oxf) 43 1995 197 203 [PubMed: 7554315]